1. Home
  2. CLDX vs BV Comparison

CLDX vs BV Comparison

Compare CLDX & BV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • BV
  • Stock Information
  • Founded
  • CLDX N/A
  • BV 1939
  • Country
  • CLDX United States
  • BV United States
  • Employees
  • CLDX N/A
  • BV N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • BV Business Services
  • Sector
  • CLDX Health Care
  • BV Consumer Discretionary
  • Exchange
  • CLDX Nasdaq
  • BV Nasdaq
  • Market Cap
  • CLDX 1.4B
  • BV 1.4B
  • IPO Year
  • CLDX 2008
  • BV 2018
  • Fundamental
  • Price
  • CLDX $22.08
  • BV $14.39
  • Analyst Decision
  • CLDX Strong Buy
  • BV Buy
  • Analyst Count
  • CLDX 9
  • BV 7
  • Target Price
  • CLDX $46.13
  • BV $17.82
  • AVG Volume (30 Days)
  • CLDX 1.5M
  • BV 946.9K
  • Earning Date
  • CLDX 08-07-2025
  • BV 08-06-2025
  • Dividend Yield
  • CLDX N/A
  • BV N/A
  • EPS Growth
  • CLDX N/A
  • BV N/A
  • EPS
  • CLDX N/A
  • BV 0.12
  • Revenue
  • CLDX $5,790,000.00
  • BV $2,698,700,000.00
  • Revenue This Year
  • CLDX N/A
  • BV $0.10
  • Revenue Next Year
  • CLDX N/A
  • BV $2.09
  • P/E Ratio
  • CLDX N/A
  • BV $121.30
  • Revenue Growth
  • CLDX N/A
  • BV N/A
  • 52 Week Low
  • CLDX $14.40
  • BV $11.81
  • 52 Week High
  • CLDX $47.00
  • BV $18.89
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 47.99
  • BV 37.87
  • Support Level
  • CLDX $21.34
  • BV $14.45
  • Resistance Level
  • CLDX $23.27
  • BV $14.85
  • Average True Range (ATR)
  • CLDX 1.54
  • BV 0.36
  • MACD
  • CLDX -0.15
  • BV -0.02
  • Stochastic Oscillator
  • CLDX 33.75
  • BV 7.80

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About BV BrightView Holdings Inc.

BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature. It includes mowing, gardening, mulching and snow removal, water management etc. And Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.

Share on Social Networks: